Amgen Tour of California, presented by AEG, the world’s leading sports and live entertainment company, announced that professional cycling will return to Lake Tahoe from May 11 to 12, 2017.
Courtesy Amgen Tour of California
The Amgen Breakaway from Heart Disease Women’s Race Empowered with SRAM will include the overall start and Stage 2 on consecutive days. The women’s competition will conclude with a third stage in Elk Grove, May 13 and the final in Sacramento, May 14.
The women will start with one of the most beautiful race routes in the USA, circumnavigating the 72-mile shoreline of Lake Tahoe with the final climb that will lead riders to the finish at Heavenly Mountain Resort. A new Stage 2 route will be announced early 2017 where riders will face summits in excess of 7,300-feet leading to what promises to be a climatic finish. The upcoming race marks the 10th consecutive year that a women’s competition is a major component of the Amgen Tour of California.
“After the 2016 summer Olympic Games women’s cycling reached a new level and watching these elite athletes here in our backyard lends a new level of appreciation,” said Carol Chaplin, president and CEO of the Lake Tahoe Visitors Authority, in a press release. “Tahoe South and our partners look forward to celebrating Tahoe as a cycling mecca for top competitors as well as recreational enthusiasts.”
“The Amgen Tour of California has long been the most esteemed cycling race in America. Its designation as a UCI WorldTour event will continue to expand its international exposure and attract the best teams and cyclists yet, giving fans even more to cheer about from the streets of California next spring,” said Kristin Klein, president of the Amgen Tour of California and executive vice president of AEG Sports. | amgentourofcalifornia.com